Abstract: TTV is an unenveloped circular single-stranded DNA
virus with a diameter of 30-32 nm that first was described in 1997 in
Japan. TTV was detected in various populations without proven
pathology, including blood donors and in patients with chronic HBV
and HCV hepatitis. The aim of this study was to determine the
prevalence of TTV DNA in Iranian patients with chronic hepatitis B
and C. Viral TTV-DNA was studied in 442 samples (202 with HBV,
138 with HCV and 102 controls) collected from west south of Iran.
All extracted serum DNA was amplified by TTV ORF1 gene specific
primers using the semi nested PCR technique. TTV DNA was
detected in the serum of 8.9% and 10.8% patients with chronic
hepatitis B and C, respectively. Prevalence of TTV-DNA in the serum
of 102 controls was 2.9%. Results showed significant relation of TTV
with HBV and HCV in patients by using T test examination (P
Abstract: The study was conducted to investigate the profile of
hepatitis in Kingdom of Saudi Arabia, and to determine which age
group hepatitis viruses most commonly infect. The epidemiology of
viral hepatitis in Saudi Arabia has undergone major changes,
concurrent with major socioeconomic developments over the last two
to three decades. This disease represents a major public health
problem in Saudi Arabia resulting in the need for considerable
healthcare resources. A retrospective cross sectional analysis of the
reported cases of viral hepatitis was conducted based on the reports
of The Ministry of Health in Saudi Arabia about Hepatitis A, B and C
infections in all regions from the period of January 2006 to December
2010. The study demonstrated that incidence of viral Hepatitis is
decreasing, except for Hepatitis B that showed minimal increase. Of
hepatitis A, B, and C, Hepatitis B virus (HBV) was the most
predominant type, accounting for (53%) of the cases, followed by
Hepatitis C virus (HCV) (30%) and HAV (17%). HAV infection
predominates in children (5–14 years) with 60% of viral hepatitis
cases, HBV in young adults (15–44 years) with 69% of viral hepatitis
cases, and HCV in older adults (>45 years) with 59% of viral
hepatitis cases. Despite significant changes in the prevalence of viral
hepatitis A, B and C, it remains a major public health problem in
Saudi Arabia; however, it showed a significant decline in the last two
decades that could be attributed to the vaccination programs and the
improved health facilities. Further researches are needed to identify
the risk factors making a specific age group or a specific region in
Saudi Arabia targeted for a specific type of hepatitis viruses.